Inclusive of all taxes
CARDINOL PLUS Tablet by Dr Precision is an advanced fixed-dose combination medication combining Metoprolol Succinate and Hydrochlorothiazide, designed for the comprehensive management of hypertension and associated cardiovascular conditions. This dual-action formulation effectively controls elevated blood pressure by targeting two distinct physiological pathways — cardiac output reduction via Metoprolol Succinate, a cardioselective beta-1 blocker, and plasma volume reduction via Hydrochlorothiazide, a thiazide diuretic. The extended-release Metoprolol component ensures consistent 24-hour blood pressure control and reduces heart rate and myocardial workload, beneficial for patients with angina, arrhythmias, and post-myocardial infarction. Meanwhile, Hydrochlorothiazide promotes sodium and water excretion, lowering peripheral resistance and intravascular volume, which is critical in salt-sensitive hypertensive patients. Manufactured under GMP-compliant standards by BluepillExpress, CARDINOL PLUS guarantees high-quality, safe, and reliable therapy with superior patient compliance due to once-daily dosing. It is particularly recommended for patients not responding sufficiently to monotherapy, those with heart failure, ischemic heart disease, or left ventricular hypertrophy. By combining these two agents, CARDINOL PLUS Tablet offers enhanced antihypertensive efficacy, reduced cardiovascular risk, and improved protection against complications such as stroke, renal failure, and myocardial infarction.
Key Features
| Features | Description |
|---|---|
| Active Ingredients | Metoprolol Succinate and Hydrochlorothiazide |
| Therapeutic Action | Dual-action antihypertensive combination targeting cardiac output and fluid volume |
| Formulation Type | Extended-release tablet for once-daily dosing |
| Manufacturer | BluepillExpress under Dr Precision label |
| Indications | Management of hypertension and related cardiovascular conditions |
| Benefits | Reduces blood pressure, heart rate, cardiovascular risk, and protects organs |
| Quality Standards | GMP compliant manufacturing ensuring safety and efficacy |
| Patient Compliance | Once daily dosing with consistent 24-hour blood pressure control |
| Additional Uses | Effective in patients with heart failure, ischemic heart disease, left ventricular hypertrophy |
| Attributes | Description |
|---|---|
| Metoprolol Succinate Dose | Optimized fixed dose per tablet |
| Hydrochlorothiazide Dose | Optimized fixed dose per tablet |
| Tablet Type | Oral extended-release tablet |
| Storage Conditions | Store in a cool, dry place away from direct sunlight |
| Packaging | Available in blister packs/bottles as per market requirements |
| GMP Compliance | Manufactured according to Good Manufacturing Practices |
| Therapeutic Class | Beta-blocker and Thiazide diuretic combination |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
CARDINOL PLUS combines Metoprolol's beta-1 selective beta-blocking action with Hydrochlorothiazide's diuretic effect, providing dual mechanisms of blood pressure control addressing both cardiac output and fluid volume, resulting in enhanced antihypertensive efficacy and cardiovascular risk reduction compared to monotherapy.
The extended-release formulation of Metoprolol Succinate in CARDINOL PLUS ensures a steady, 24-hour consistent blood pressure control, reducing peak-trough fluctuations, improving patient compliance through once-daily dosing, and minimizing potential side effects.
Yes, CARDINOL PLUS is particularly beneficial for hypertensive patients with coexisting ischemic heart disease and heart failure due to Metoprolol's cardioprotective beta-blocker effects combined with volume reduction by Hydrochlorothiazide.
Yes, Hydrochlorothiazide in CARDINOL PLUS is proven to reduce the risk of stroke and congestive heart failure, while combined cardiovascular protection from both active ingredients helps lower the chances of renal failure and other hypertensive complications.
CARDINOL PLUS incorporates two effective agents into a single once-daily extended-release tablet, simplifying medication regimens to enhance adherence and ensure consistent blood pressure control over 24 hours.
Country Of Origin: India
CARDINOL PLUS Tablet is a fixed-dose combination of Metoprolol Succinate and Hydrochlorothiazide, primarily prescribed for the effective management of hypertension (high blood pressure) and related cardiovascular conditions. By combining a cardioselective beta-blocker and a thiazide diuretic, CARDINOL PLUS offers dual-action blood pressure control, reduction of cardiovascular risk, and organ protection. Manufactured under international quality standards by BluepillExpress, this formulation provides enhanced therapeutic efficacy, excellent patient compliance, and consistent safety across diverse patient populations.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
CARDINOL PLUS Tablet is a pharmacologically advanced combination therapy designed to control elevated blood pressure and reduce the risk of cardiovascular morbidity and mortality. It contains Metoprolol Succinate, a selective beta-1 adrenergic receptor blocker, and Hydrochlorothiazide, a thiazide diuretic, in an optimized fixed dose that offers both heart rate control and volume reduction. Together, these agents address two different mechanisms of blood pressure elevation—cardiac output and fluid overload—leading to superior antihypertensive efficacy compared to monotherapy.
Metoprolol Succinate, the primary component of CARDINOL PLUS, is a beta-1 selective beta-blocker known for its efficacy in reducing heart rate, cardiac workload, and blood pressure. It works by blocking the beta-1 receptors in the heart, leading to a decrease in heart rate and myocardial contractility. This results in reduced oxygen demand, making Metoprolol particularly beneficial in hypertensive patients with angina, arrhythmias, or post-myocardial infarction status. Its once-daily extended-release formulation ensures consistent 24-hour blood pressure control, minimizing peak-trough fluctuations and enhancing patient compliance.
Hydrochlorothiazide complements Metoprolol by promoting renal excretion of sodium and water, thereby reducing intravascular volume and decreasing peripheral resistance. As a thiazide diuretic, it is especially effective in salt-sensitive hypertensive patients and contributes to long-term blood pressure regulation. Moreover, Hydrochlorothiazide has been shown to reduce the risk of stroke and congestive heart failure in hypertensive individuals, making it a valuable addition to this combination therapy.
CARDINOL PLUS Tablet is indicated for patients who require combination therapy for hypertension, especially those not adequately controlled with beta-blocker monotherapy. It is particularly useful in patients with coexisting heart failure, ischemic heart disease, or left ventricular hypertrophy. The dual action ensures a comprehensive approach to cardiovascular protection, reducing the chances of complications such as stroke, myocardial infarction, renal failure, and aortic dissection.
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
